Alerts
View all our safety alerts, medicine shortage alerts and product recalls.
Loading...
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Shortages (4)
- Alert/Advisory (44)
- Medicine safety (32)
- Safety (28)
- Medical devices safety (17)
- Regulatory compliance (9)
- Import and export (8)
- Prescription medicines (8)
- Over the counter (OTC) medicines (7)
- Therapeutic goods regulation (7)
- Australian Register of Therapeutic Goods (ARTG) (6)
- Listed medicines (6)
- Complementary medicines (4)
- Advertising (3)
- Non-prescription medicines (3)
- Sunscreens (3)
- Labelling and packaging (2)
- Legislation (2)
- Weight loss products (1)
Search
4 result(s) found, displaying 1 to 4
-
Medicine shortage alertsRitalin and Artige immediate-release tablets are now also in shortage, and a shortage of Ritalin LA capsules is anticipated.
-
Market actionsTakeda Pharmaceuticals Australia has issued a product alert for Vyvanse capsules due to minor packaging errors. The medication is safe to use as prescribed.
-
Safety alertsThe TGA is warning consumers against taking EVE branded products that contain allylisopropylacetylurea (apronal) as they pose a significant health risk and are prohibited from sale, supply or use in Australia.
-
Safety alertsThe TGA has detected fake semaglutide, also known as Ozempic, being illegally imported into Australia.